To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

NCT04058067 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Brolucizumab
DRUG: Aflibercept

Sponsor

Novartis Pharmaceuticals